Annual Meeting > Allied Sessions
2017 SGO Annual Meeting Allied Sessions
Allied sessions are geared towards Advanced Practitioners (APs) such as nurse practitioners, physician assistants, clinical pharmacists, and clinical nurse specialists who are a part of a woman’s gynecologic cancer care team.
Advanced Practitioners Dinner Symposium: Genetic Counseling in Gynecologic Oncology: What Advanced Practitioners Need to Know
Saturday, March 11, 2017
6:30 p.m. – 8:30 p.m.
Registration: To register for this symposium, please log in to your Annual Meeting registration account through our online system, and add the session to your schedule.
Description: The Society for Gynecologic Oncology (SGO), the Advanced Practitioner Society for Hematology and Oncology (APSHO) and Harborside Medical Education invite allied health practitioners in the subspecialty of gynecologic oncology to a dinner symposium during SGO’s Annual Meeting on Women’s Cancer. This course is geared towards Advanced Practitioners (APs) such as nurse practitioners, physician assistants, clinical pharmacists, and clinical nurse specialists.
Allied heath attendees will gain a deeper understanding of the role of genetic testing and counseling in the oncology setting, be better equipped to make appropriate recommendations for counseling and have the tools to communicate effectively to patients. After attending this course, participants will be able to:
- Demonstrate increased understanding of the role genetic testing and counseling play in the oncology setting
- Discuss the difference in germline and somatic gene mutation and make appropriate recommendations for counseling
- Identify appropriate key points in the patient/family history for genetic counseling referral and/or genetic testing
- Discuss the various patient communication tools to convey pertinent information on genetic testing and counseling
Content from this meeting will be published in the Journal of the Advanced Practitioner in Oncology, the official publication of APSHO, in November/December 2017. This activity is supported by AstraZeneca. Content and CME will be provided by SGO.
Sunday, March 12, 2017
3:30 p.m. – 5:30 p.m.
Course Director: Sarah Bernstein RN, MS, AOCN
Description: This session will enable attendees to understand the guidelines for long-term monitoring and bone health care, as well as the effects of chemotherapy, biotherapy, radiation, and the post-menopausal status on bone health in gynecologic oncology patients.
Scheduled topics include:
- The effects of chemotherapy, biotherapy, radiation and the postmenopausal status on bone health in the gynecologic oncology patient.
- Skeletal Health:
What are the current standards to monitor and assess bone health in the GYN oncology patient?
What is the treatment for patients with bone metastasis and/or bone loss, in the patients under active treatment and those post treatment?
What are the guidelines for long term monitoring and bone health care?
- Potential complications of pharmacologic therapies:
Case study presentation of osteonecrosis of the jaw.